Covalon Technology Limited (COV)

[zenvesting]

It's not necessarily bad either, at least Covalon wrote a strong agreement that assured a better minimum sales performance than we've seen and allows them to claw back their products/technology if the sales goals aren't met.

Looking back at their sales history since IV Clear & SurgiClear received it's FDA clearance (5/2012 & 8/2012), it looks like Covalon was doing better than Molnlycke with marketing it, so I think Covalon could actually do better on their own again. Molnlycke's performance over the past two years might be the bigger disappointment. Given Covalon's strong sales performance with the rest of their product line over the past couple of years, I'm willing to give them a couple more quarters to see what they can do when they get IV Clear and SurgiClear back in their distribution channels.

I just wonder if Molnlycke will continue to market the product non-exclusively, as Covalon allowed Smith&Nephew to do with BIOSTEP, or if Covalon will take it all back to have the possibility to offer another exclusive license for it.

But overall, Covalon's sales are growing again now due to it's growing distribution network and product line..... and I imagine they will get even better if they can add Mepitel Film AM back into the mix...